These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 31269656

  • 1. Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate.
    Moural TW, White DS, Choy CJ, Kang C, Berkman CE.
    Int J Mol Sci; 2019 Jul 02; 20(13):. PubMed ID: 31269656
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F, Cassidy C, Sacchettini JC.
    Antimicrob Agents Chemother; 2006 Aug 02; 50(8):2762-71. PubMed ID: 16870770
    [Abstract] [Full Text] [Related]

  • 6. NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis.
    Xu H, Hazra S, Blanchard JS.
    Biochemistry; 2012 Jun 05; 51(22):4551-7. PubMed ID: 22587688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG, Wolff KA, Hazra S, Bethel CR, Hujer AM, Smith KM, Xu Y, Tremblay LW, Blanchard JS, Nguyen L, Bonomo RA.
    Antimicrob Agents Chemother; 2013 Dec 05; 57(12):6085-96. PubMed ID: 24060876
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against Sulbactam.
    van Alen I, Chikunova A, Safeer AA, Ahmad MUD, Perrakis A, Ubbink M.
    Biochemistry; 2021 Jul 20; 60(28):2236-2245. PubMed ID: 34250791
    [Abstract] [Full Text] [Related]

  • 11. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
    Egesborg P, Carlettini H, Volpato JP, Doucet N.
    Protein Sci; 2015 Apr 20; 24(4):534-44. PubMed ID: 25492589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis.
    Nantongo M, Nguyen DC, Bethel CR, Taracila MA, Li Q, Dousa KM, Shin E, Kurz SG, Nguyen L, Kreiswirth BN, Boom WH, Plummer MS, Bonomo RA.
    ACS Infect Dis; 2024 May 10; 10(5):1767-1779. PubMed ID: 38619138
    [Abstract] [Full Text] [Related]

  • 15. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D, Li de la Sierra-Gallay I, Dubée V, Triboulet S, van Tilbeurgh H, Compain F, Ballell L, Barros D, Mainardi JL, Hugonnet JE, Arthur M.
    Antimicrob Agents Chemother; 2015 Sep 10; 59(9):5714-20. PubMed ID: 26149997
    [Abstract] [Full Text] [Related]

  • 16. High-throughput fluorescent screening of β-lactamase inhibitors to improve antibiotic treatment strategies for tuberculosis.
    Yan F, He S, Han X, Wang J, Tian X, Wang C, James TD, Cui J, Ma X, Feng L.
    Biosens Bioelectron; 2022 Nov 15; 216():114606. PubMed ID: 35952435
    [Abstract] [Full Text] [Related]

  • 17. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Dubée V, Soroka D, Cortes M, Lefebvre AL, Gutmann L, Hugonnet JE, Arthur M, Mainardi JL.
    Antimicrob Agents Chemother; 2015 May 15; 59(5):2938-41. PubMed ID: 25733512
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors.
    Nguyen TV, Blackledge MS, Lindsey EA, Minrovic BM, Ackart DF, Jeon AB, Obregón-Henao A, Melander RJ, Basaraba RJ, Melander C.
    Angew Chem Int Ed Engl; 2017 Mar 27; 56(14):3940-3944. PubMed ID: 28247991
    [Abstract] [Full Text] [Related]

  • 20. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
    Flores AR, Parsons LM, Pavelka MS.
    Microbiology (Reading); 2005 Feb 27; 151(Pt 2):521-532. PubMed ID: 15699201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.